ANKTIVA shared on X:
“ Dr. Karen Knudsen, CEO of the Parker Institute for Cancer Immunotherapy, joined Cuomo, together with Pat Soon-Shiong,
‘I agree that the immune system and immunology is how we are going to cure cancer.”
From the video, the main points/topics are:
- Cancer isn’t one disease. The discussion treats cancer as a very large group of biologically different diseases, which makes the idea of one universal “cure” unrealistic.
- Cancer mortality has improved substantially, but the progress is uneven between cancer types. The graphic shown in your clip compares long-term cancer death-rate trends for men and women.
- They discuss five-year survival rates and how these have changed over time. The graphic specifically compares breast, colorectal, lung, ovarian, pancreatic and prostate cancers.
- A major theme is why some cancers remain much harder to treat, particularly cancers that are diagnosed late or develop resistance to treatment.
- Knudsen is speaking from the perspective of cancer research and immunotherapy, so the conversation also connects the problem to advances in immune-based treatments and the need to translate research into effective treatments for patients.
- The broader special brings together NIH/NCI leadership, FDA expertise, cancer researchers and patients to discuss what is slowing progress and what could accelerate it.
The Big Questions in Cancer Immunotherapy: Can We Build an Immune System Inside the Tumor?
